BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4032132)

  • 1. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R; Forster J; Kuhn W; Ziupa J
    J Pediatr; 1985 Sep; 107(3):367-71. PubMed ID: 4032132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
    Ferrante A; Mocatta F; Goh DH
    Int Arch Allergy Appl Immunol; 1986; 81(3):284-7. PubMed ID: 3770979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bee venom immunotherapy: clinical and immunologic observations.
    Bar-Sela S; Levo Y
    Ann Allergy; 1981 Dec; 47(6):460-3. PubMed ID: 7325420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of specific IgG antibodies in insect sting allergy.
    Urbanek R; Forster J; Karitzky D; Ziupa J
    Eur J Pediatr; 1981 Mar; 136(1):31-4. PubMed ID: 7215389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R; Kemeny DM; Richards D
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG and IgE antibodies after immunotherapy with bee and wasp venom.
    Kemeny DM; Lessof MH; Patel S; Youlten LJ; Williams A; Lambourn E
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):247-9. PubMed ID: 2707888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bee sting allergy in beekeepers.
    Eich-Wanger C; Müller UR
    Clin Exp Allergy; 1998 Oct; 28(10):1292-8. PubMed ID: 9824397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.
    Busse WW; Reed CE; Lichtenstein LM; Reisman RE
    JAMA; 1975 Mar; 231(11):1154-6. PubMed ID: 1172815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insect allergy. A comparative study including case histories and immunological parameters.
    Mosbech H
    Allergy; 1984 Oct; 39(7):543-9. PubMed ID: 6496884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment.
    Thurnheer U; Müller U; Stoller R; Lanner A; Hoigné R
    Allergy; 1983 Oct; 38(7):465-75. PubMed ID: 6638413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R; Wüthrich B; Marti-Wyss S; Cuhat J
    Schweiz Med Wochenschr; 1987 Oct; 117(44):1728-35. PubMed ID: 3685930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.
    Müller U; Helbling A; Bischof M
    Allergy; 1989 Aug; 44(6):412-8. PubMed ID: 2802114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy to venom from bee or wasp: the relation between clinical and immunological reactions to insect stings.
    Heinig JH; Engel T; Weeke ER
    Clin Allergy; 1988 Jan; 18(1):71-8. PubMed ID: 3349594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.